Landos Biopharma Stock (NASDAQ: LABP) stock price, news, charts, stock research, profile.
Open | $21.700 |
Close | $21.820 |
Volume / Avg. | 14.682K / 25.561K |
Day Range | 21.600 - 21.820 |
52 Wk Range | 2.500 - 21.870 |
Market Cap | $67.063M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 94 |
Short Interest | 0.3% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Landos Biopharma (NASDAQ: LABP) through any online brokerage.
Other companies in Landos Biopharma’s space includes: SCYNEXIS (NASDAQ:SCYX), Jaguar Health (NASDAQ:JAGX), CalciMedica (NASDAQ:CALC), Ocuphire Pharma (NASDAQ:OCUP) and Lipocine (NASDAQ:LPCN).
The latest price target for Landos Biopharma (NASDAQ: LABP) was reported by HC Wainwright & Co. on Monday, April 1, 2024. The analyst firm set a price target for 20.42 expecting LABP to fall to within 12 months (a possible -5.02% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Landos Biopharma (NASDAQ: LABP) is $21.5 last updated April 10, 2024 at 8:43 AM EDT.
There are no upcoming dividends for Landos Biopharma.
Landos Biopharma’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Landos Biopharma.
Landos Biopharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.